We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2006 by Far Eastern Memorial Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00318604
First Posted: April 27, 2006
Last Update Posted: May 12, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Far Eastern Memorial Hospital
  Purpose
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.

Condition
Head and Neck Cancer Esophageal Cancer

Study Type: Observational
Study Design: Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Far Eastern Memorial Hospital:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Head and neck cancers
  • Esophageal cancer
  • Undergoing anti-cancer treatments

Exclusion Criteria:

  • No distant metastasis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00318604


Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Principal Investigator: LeJung Wu, MD, DPhil Far Eastern Memorial Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00318604     History of Changes
Other Study ID Numbers: 94042
First Submitted: April 25, 2006
First Posted: April 27, 2006
Last Update Posted: May 12, 2006
Last Verified: April 2006

Keywords provided by Far Eastern Memorial Hospital:
plasma circulating DNA
hean and neck cancers
esophageal cancer
localized head and neck cancers
localized esophageal cancer

Additional relevant MeSH terms:
Head and Neck Neoplasms
Esophageal Neoplasms
Neoplasms by Site
Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Digestive System Diseases
Esophageal Diseases
Gastrointestinal Diseases